
May 1, 2023
RegMed Investors’ (RMi) pre-open: share pricing trouble coming, just a matter of when?
April 28, 2023
RegMed Investors’ (RMi) pre-open: how now brown cow?
April 27, 2023
RegMed Investors’ (RMi) closing bell: the market moved up, the cell and gene therapy sector traveled with it
April 27, 2023
RegMed Investors’ (RMi) pre-open: plug-in and recharge the sector and show me some upside
April 26, 2023
RegMed Investors’ (RMi) closing bell: Uncle algo showed briefly and left early
April 26, 2023
RegMed Investors’ (RMi) pre-open: Uncle algorithm coming to rescue the oversold?
April 25, 2023
RegMed Investors’ (RMi) closing bell: cell and gene therapy sector shillyshallies and then quivers
April 25, 2023
RegMed Investors’ (RMi) pre-open: show me some money, any and more upside
April 24, 2023
RegMed Investors’ (RMi) closing bell: calling the ball on underperforming share pricing, just too many factors to list
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors